Assessment of the safety of long-term nicotinamide mononucleotide (NMN) in healthy subjects; phase II study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2017
INTERVENTION: long‐term (8 weeks) intake of NMN CONDITION: healthy subjects PRIMARY OUTCOME: the safety of long‐term (8weeks) NMN (physical and laboratory examinations). SECONDARY OUTCOME: 1.the kinetics of NMN and metabolites of nicotinamide.; ; 2.the effect of daily NMN admnistration on glucose metabolism INCLUSION CRITERIA: the healthy subjects who agree to the study.
Epistemonikos ID: 04c397b0f1e3ef79b292fbb0bc74ff0afdfe1097
First added on: Dec 20, 2022